Litigation

Recent Posts

Hunter Shkolnik Of Rheingold Valet Moves To Napoli Bern Ripka LLP
Posted on 4 Aug 2011 by LexisNexis Litigation Resource Community Staff

NEW YORK - After more than 15 years as a senior partner in the New York personal injury firm Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP, Hunter Shkolnik has joined Napoli Bern Ripka LLP as a senior partner of the firm, which is now known... Read More

Federal Food, Drug, And Cosmetic Act Did Not Preclude Lanham Act Challenge That Asserted That Labeling, Marketing, And Advertising Was Misleading
Posted on 1 Jul 2014 by LexisNexis Legal Newsroom Staff

On June 12, 2014, the United States Supreme Court decided the case of POM Wonderful LLC v. Coca-Cola Co., 189 L. Ed. 2d 141 (U.S. 2014) . POM Wonderful, LLC (POM) filed its initial action against Coca-Cola asserting that the labeling, marketing, and advertising... Read More

Virginia Federal Jury Says Woman Didn't Prove Prempro Warnings Were Inadequate
Posted on 3 Dec 2010 by Tom Moylan

ALEXANDRIA, Va. - (Mealey's) A Virginia federal jury on Dec. 3 found that a woman who claimed to have developed breast cancer from taking Wyeth's Prempro hormone replacement therapy drug did not prove that warnings provided to her doctor were... Read More

AstraZeneca Wins Patent Dispute Over Crestor
Posted on 30 Jun 2010 by LexisNexis Litigation Resource Community Staff

NEW YORK - (AP) AstraZeneca Plc said Tuesday it won a patent challenge brought against its blockbuster cholesterol drug Crestor by generic drug developers. The U.S. District Court in Delaware ruled that a key patent on the company's third best-selling... Read More

AstraZeneca Pays $198M To Settle Seroquel Lawsuits
Posted on 9 Aug 2010 by LexisNexis Litigation Resource Community Staff

LONDON - (AP) AstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug Seroquel. Full version available to lexis.com subscriber . Read More